TempraMed Granted Mexican Patent for Newest Product, VIVI Box
Grant in Mexico marks a major milestone in global IP strategy, advancing protection of its VIVI Box platform across key international markets
Highlights
- Covers core innovations underpinning TempraMed's VIVI Box™ multi-medication storage platform
- Strengthens the Company's intellectual property position in one of the world's largest healthcare and consumer markets
- Supports commercialization strategy and strategic engagement with appliance manufacturers across America's premium refrigeration sector
- Patent term extends through October 24, 2039
Vancouver, British Columbia--(Newsfile Corp.

